
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
New Orleans - Tacrolimus ointment (Protopic) shows promise as an innovative new topical treatment for vitiligo, Pearl E. Grimes, M.D., said at the annual meeting of the American Academy of Dermatology.